Genetron Holdings Limited logo
Genetron Holdings Limited GTH
$ 4.03 0.12%

Annual report 2022
added 12-21-2024

report update icon

Genetron Holdings Limited Financial Statements 2011-2025 | GTH

Annual Financial Statements Genetron Holdings Limited

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

- 1.54 B 1.66 B 250 M 60.1 M 116 M - - - - - -

Shares

- 461 M 67.7 M 67.7 M 69.1 M 67.7 M - - - - - -

Historical Prices

0.87 3.35 24.6 - - - - - - - - -

Net Income

- -503 M -3.07 B -676 M -465 M -421 M - - - - - -

Revenue

651 M 532 M 424 M 323 M 225 M 101 M - - - - - -

Cost of Revenue

- 194 M 164 M 178 M 132 M - - - - - - -

Gross Profit

281 M 338 M 260 M 145 M 92.7 M 26.8 M - - - - - -

Operating Income

- -518 M -268 M -307 M -233 M - - - - - - -

EBITDA

- -518 M -268 M -307 M -233 M -134 M - - - - - -

Operating Expenses

983 M 856 M 529 M 452 M 326 M 181 M - - - - - -

General and Administrative Expenses

- - 126 M 117 M 88.2 M 45.5 M - - - - - -

All numbers in CNY currency

Quarterly Income Statement Genetron Holdings Limited

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

All numbers in CNY currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements Genetron Holdings Limited GTH
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting Genetron Holdings Limited plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Diagnostics research industry

Issuer Price % 24h Market Cap Country
Centogene N.V. Centogene N.V.
CNTG
$ 0.33 -6.23 % $ 30.6 M germanyGermany
Fluidigm Corporation Fluidigm Corporation
FLDM
$ 3.75 1.08 % $ 308 M usaUSA
Global Cord Blood Corporation Global Cord Blood Corporation
CO
$ 2.99 - $ 399 M chinaChina
Oxford Immunotec Global PLC Oxford Immunotec Global PLC
OXFD
$ 21.99 - $ 562 M britainBritain
Chembio Diagnostics Chembio Diagnostics
CEMI
$ 0.46 0.22 % $ 16.8 M usaUSA
Pacific Biosciences of California Pacific Biosciences of California
PACB
$ 1.97 -5.74 % $ 500 M usaUSA
Koninklijke Philips N.V. Koninklijke Philips N.V.
PHG
$ 27.3 -5.5 % $ 20 B niderlandNiderland
Meridian Bioscience Meridian Bioscience
VIVO
$ 33.97 - $ 1.49 B usaUSA
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
$ 0.48 -20.0 % $ 1.06 M usaUSA
Quotient Limited Quotient Limited
QTNT
$ 0.32 -11.32 % $ 1.1 M schweizSchweiz
Bioventus Bioventus
BVS
$ 6.94 3.43 % $ 435 M usaUSA
PRA Health Sciences, Inc. PRA Health Sciences, Inc.
PRAH
$ 165.21 - $ 10.7 B usaUSA
Thermo Fisher Scientific Thermo Fisher Scientific
TMO
$ 557.63 -1.09 % $ 213 B usaUSA
Trinity Biotech plc Trinity Biotech plc
TRIB
$ 1.0 -1.96 % $ 61.9 M irlandaIrlanda
Heska Corporation Heska Corporation
HSKA
$ 119.99 - $ 1.31 B usaUSA
Twist Bioscience Corporation Twist Bioscience Corporation
TWST
$ 33.57 -1.78 % $ 1.95 B usaUSA
Motus GI Holdings Motus GI Holdings
MOTS
$ 0.17 -34.28 % $ 263 K israelIsrael
Biocept Biocept
BIOC
$ 0.43 -13.05 % $ 7.29 M usaUSA
Syneos Health Syneos Health
SYNH
$ 42.98 - $ 4.46 B usaUSA
Invitae Corporation Invitae Corporation
NVTA
$ 0.09 - $ 21.2 M usaUSA
DermTech DermTech
DMTK
$ 0.09 -11.32 % $ 2.94 M usaUSA
Akumin Akumin
AKU
$ 0.29 -17.87 % $ 25.9 M canadaCanada
Castle Biosciences Castle Biosciences
CSTL
$ 24.15 0.79 % $ 671 M usaUSA
DarioHealth Corp. DarioHealth Corp.
DRIO
$ 15.33 -2.67 % $ 435 M israelIsrael
Exagen Exagen
XGN
$ 11.89 -0.17 % $ 210 M usaUSA
PerkinElmer PerkinElmer
PKI
$ 115.24 -0.91 % $ 14.7 B usaUSA
OpGen OpGen
OPGN
$ 1.96 -16.95 % $ 1.54 M usaUSA
DexCom DexCom
DXCM
$ 69.23 -1.98 % $ 26.7 B usaUSA
Organovo Holdings Organovo Holdings
ONVO
$ 2.12 -2.3 % $ 19.4 M usaUSA
Burning Rock Biotech Limited Burning Rock Biotech Limited
BNR
$ 12.26 4.79 % $ 130 M chinaChina
Danaher Corporation Danaher Corporation
DHR
$ 216.9 -1.86 % $ 159 B usaUSA
Quidel Corporation Quidel Corporation
QDEL
$ 28.19 -4.38 % $ 1.19 B usaUSA
Neogen Corporation Neogen Corporation
NEOG
$ 6.16 -0.81 % $ 1.34 B usaUSA
Biomerica Biomerica
BMRA
$ 2.93 -1.15 % $ 6.73 M usaUSA
Fulgent Genetics Fulgent Genetics
FLGT
$ 23.43 0.51 % $ 708 M usaUSA
Psychemedics Corporation Psychemedics Corporation
PMD
$ 2.67 -1.84 % $ 15.3 M usaUSA
Genetic Technologies Limited Genetic Technologies Limited
GENE
$ 0.77 - $ 7.1 B australiaAustralia
Myriad Genetics Myriad Genetics
MYGN
$ 8.13 0.37 % $ 737 M usaUSA
Renalytix AI plc Renalytix AI plc
RNLX
$ 0.21 5.66 % $ 22.7 M britainBritain
Medpace Holdings Medpace Holdings
MEDP
$ 580.53 -2.67 % $ 18 B usaUSA
IQVIA Holdings IQVIA Holdings
IQV
$ 218.13 0.32 % $ 39.5 B usaUSA
CareDx, Inc CareDx, Inc
CDNA
$ 14.67 1.1 % $ 789 M usaUSA
Brainsway Ltd. Brainsway Ltd.
BWAY
$ 16.59 -2.5 % $ 99.4 M israelIsrael
Biodesix Biodesix
BDSX
$ 6.55 -1.5 % $ 849 M usaUSA
T2 Biosystems T2 Biosystems
TTOO
$ 0.12 -39.35 % $ 313 K usaUSA
Guardant Health Guardant Health
GH
$ 69.58 -1.79 % $ 8.54 B usaUSA
Agilent Technologies Agilent Technologies
A
$ 145.85 -0.5 % $ 44.3 B usaUSA
Co-Diagnostics Co-Diagnostics
CODX
$ 0.57 -54.76 % $ 16.7 M usaUSA
Lantheus Holdings Lantheus Holdings
LNTH
$ 57.33 -1.38 % $ 3.97 B usaUSA